DIA435.72-5.61 -1.27%
SPX6,238.01-101.38 -1.60%
IXIC20,650.13-472.32 -2.24%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·02/10/2023 17:31:09
Listen to the news

Gainers

  • Hillstream BioPharma (NASDAQ:HILS) shares moved upwards by 84.7% to $2.18 during Friday's regular session. As of 12:30 EST, Hillstream BioPharma's stock is trading at a volume of 81.2 million, which is 5053.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.1 million.
  • Vallon Pharmaceuticals (NASDAQ:VLON) stock increased by 58.16% to $0.42. As of 12:30 EST, Vallon Pharmaceuticals's stock is trading at a volume of 46.1 million, which is 1867.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.7 million.
  • VistaGen Therapeutics (NASDAQ:VTGN) shares increased by 36.37% to $0.19. Trading volume for this security as of 12:30 EST is 22.3 million, which is 315.1% of its average full-day volume over the last 100 days. The company's market cap stands at $42.3 million. As per the news, the Q3 earnings report came out 3 days ago.
  • Lixte Biotech Hldgs (NASDAQ:LIXT) stock moved upwards by 17.42% to $1.28. Lixte Biotech Hldgs's stock is trading at a volume of 10.4 million shares as of 12:30 EST. This is 1063.0% of its average full-day volume over the last 100 days. The company's market cap stands at $21.3 million.
  • Rain Oncology (NASDAQ:RAIN) stock rose 16.65% to $10.5. Rain Oncology's stock is trading at a volume of 987.1K shares as of 12:30 EST. This is 585.2% of its average full-day volume over the last 100 days. The company's market cap stands at $368.9 million.
  • Strata Skin Sciences (NASDAQ:SSKN) stock rose 14.13% to $1.19. The market value of their outstanding shares is at $41.3 million.

Losers

  • Akebia Therapeutics (NASDAQ:AKBA) stock fell 33.1% to $0.75 during Friday's regular session. Trading volume for Akebia Therapeutics's stock is 9.3 million as of 12:30 EST. This is 473.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $137.7 million.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) stock decreased by 28.21% to $8.3. The current volume of 1.3 million shares is 514.3% of Phathom Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $345.4 million.
  • Meihua Intl Medical Techs (NASDAQ:MHUA) shares fell 26.77% to $14.83. The market value of their outstanding shares is at $355.0 million.
  • Apexigen (NASDAQ:APGN) stock decreased by 20.0% to $1.08. Apexigen's stock is trading at a volume of 127.5K shares as of 12:30 EST. This is 6.6% of its average full-day volume over the last 100 days. The company's market cap stands at $26.5 million.
  • Sensus Healthcare (NASDAQ:SRTS) stock declined by 19.28% to $7.14. The current volume of 918.5K shares is 317.2% of Sensus Healthcare's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $118.6 million. As per the news, the Q4 earnings report came out yesterday.
  • Omega Therapeutics (NASDAQ:OMGA) shares decreased by 17.73% to $5.43. The current volume of 104.7K shares is 181.3% of Omega Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $260.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.